✦ LIBER ✦

Efficacy of zoledronic acid for the reduction of bone marrow tumor cells in breast cancer patients receiving adjuvant therapy

✍ Scribed by E.-F. Solomayer; T. Fehm; G. Gebauer; W. Janni; H.-J. Lück; D. Wallwiener

Book ID: 116319501
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 51 KB
Volume: 38
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2006.01.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid (ZA) as adjuvant therapy

Zoledronic acid (ZA) as adjuvant therapy for women with early stage breast cancer and disseminated tumor cells (DTC) in bone marrow (BM)

✍ A. Lin; J. Park; M. Melisko; A. Goga; M. Moasser; D. Moore; H. Rugo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Persistence of bone marrow micrometastas

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

✍ Martin J. Slade; Anjana Singh; Brendan M. Smith; Gopi Tripuraneni; Emma Hall; Cl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

We have previously developed a quantitative PCR (QPCR) technique for the detection of cytokeratin 19 (CK19) transcripts in blood and bone marrow and compared this to immunocytochemistry (ICC). Together, both have shown promise for monitoring therapeutic efficacy in patients with metastatic breast ca

Persistence of Bone Marrow Micrometastas

Persistence of Bone Marrow Micrometastases in Patients Receiving Adjuvant Therapy for Breast Cancer: Results at 4 Years

✍ Cristofanilli, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Detection of cytokeratin-positive cells

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

✍ Sven Becker; Graziella Becker-Pergola; Diethelm Wallwiener; Erich-Franz Solomaye 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 172 KB

Effect of zoledronate on persisting diss

Effect of zoledronate on persisting disseminated tumor cells (DTC) in the bone marrow (BM) of breast cancer patients

✍ B Rack; W Janni; W Thieleke; C Schindlbeck; B Strobl; C Kentenich; T Blankenstei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Zoledronic acid blocks the interaction b

Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer

✍ Gallo, M.; De Luca, A.; Lamura, L.; Normanno, N. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 535 KB